Predicting Health Utilities for Children With Autism Spectrum Disorders

Autism Research

Volumn 7, Issue 6, 2014, Pages 649-663

  Payakachat, Nalin ^a   Tilford, J Mick ^a,b   Kuhlthau, Karen A ^c,d   van Exel, N Job ^e   Kovacs, Erica ^f   Bellando, Jayne ^b   Pyne, Jeffrey M ^b,g   Brouwer, Werner B F ^e  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

^e ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^f NewYork Presbyterian Hospital   (United States)

^g CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Autism; Behavioral measure; Clinical measure; Equating measure; Health utilities; Mapping; Predictive algorithms; Quality of life measure

Indexed keywords

ADOLESCENT; AGE; ALGORITHM; ARTICLE; AUTISM; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; BEHAVIOR ASSESSMENT; CHILD; CHILD BEHAVIOR; CHILD BEHAVIOR CHECKLIST; COGNITIVE DEFECT; COMPARATIVE EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH UTILITIES INDEX MARK 3; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MOTOR PERFORMANCE; PEDIATRIC QUALITY OF LIFE INVENTORY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; SCHOOL CHILD; SOCIAL INTERACTION; SOCIALIZATION; VINELAND II ADAPTIVE BEHAVIOR SCALE; ARKANSAS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ALGORITHMS; ARKANSAS; CHILD; CHILD BEHAVIOR; CHILD DEVELOPMENT DISORDERS, PERVASIVE; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS;

EID: 84918499228     PISSN: 19393792     EISSN: 19393806     Source Type: Journal    
DOI: 10.1002/aur.1409     Document Type: Article

References (81)

1. Achenbach, T.M., & Ruffle, T.M. (2000). The Child Behavior Checklist and related forms for assessing behavioral/emotional problems and competencies. Pediatrics in Review, 21, 265-271.
2. American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-V). Arlinton, VA: American Psychiatric Publishing.
3. Bailey, A.J. (2009). Where are the autism economists? Autism Research, 2, 245.
4. Basu, A., & Manca, A. (2012). Regression estimators for generic health-related quality of life and quality-adjusted life years. Medical Decision Making, 32, 56-69.
5. Bayley, N. (2005). Bayley scales of infant and toddler development (3rd ed.). San Antonio, TX: Pearson Education, Inc.
6. Blumberg, S.J., Bramlett, M.D., Kogan, M.D., Schieve, L.A., Jones, J.R., & Lu, M.C. (2013). Changes in prevalence of parent-reported autism spectrum disorder in school-aged U.S. children: 2007 to 2011-2012 (Rep. No. 65). National Center for Health Statistics, Hyattsville, MD.
7. Brazier, J.E., Ratcliffe, J., Salomon, J., & Tsuchiya, A. (2007). Valuing health. In J.E. Brazier, J. Ratcliffe, J. Salomon, & A. Tsuchiya (Eds.), Measuring and valuing health benefits for economic evaluation (pp. 83-138). New York, NY: Oxford University Press Inc.
8. Brazier, J.E., & Roberts, J. (2004). The estimation of a preference-based measure of health from the SF-12. Medical Care, 42, 851-859.
9. Brazier, J.E., Yang, Y., Tsuchiya, A., & Rowen, D.L. (2010). A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. The European Journal of Health Economics, 11, 215-225.
10. Briggs, A.H. (2000). Handling uncertainty in cost-effectiveness models. Pharmacoeconomics, 17, 479-500.
11. Brouwer, W.B.F., Culyer, A.J., van Exel, N.J., & Rutten, F.F.H. (2008). Welfarism vs. extra-welfarism. Journal of Health Economics, 27, 325-338.
12. Buysse, C.M., Raat, H., Hazelzet, J.A., Hulst, J.M., Cransberg, K., etal. (2008). Long-term health status in childhood survivors of meningococcal septic shock. Archives of Pediatrics & Adolescent Medicine, 162, 1036-1041.
13. Centers for Disease Control and Prevention. (2012). Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008. MMWR. Surveillance Summaries: Morbidity and Mortality Weekly Report. Surveillance Summaries, 61, 1-19.
14. Chapman, R.H., Berger, M., Weinstein, M.C., Weeks, J.C., Goldie, S., & Neumann, P.J. (2004). When does quality-adjusting life-years matter in cost-effectiveness analysis? Health Economics, 13, 429-436.
15. Crott, R., & Briggs, A. (2010). Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences. European Journal of Health Economics, 11, 427-434.
16. Dakin, H., Petrou, S., Haggard, M., Benge, S., & Williamson, I. (2010). Mapping analyses to estimate health utilities based on responses to the OM8-30 otitis media questionnaire. Quality of Life Research, 19, 65-80.
17. Dawson, G., Rogers, S., Munson, J., Smith, M., Winter, J., etal. (2010). Randomized, controlled trial of an intervention for toddlers with autism: The Early Start Denver Model. Pediatrics, 125, e17-e23.
18. Dekker, M.C., Nunn, R., & Koot, H.M. (2002). Psychometric properties of the revised Developmental Behaviour Checklist scales in Dutch children with intellectual disability. Journal of Intellectual Disability Research, 46, 61-75.
19. The EuroQol Group. (1990). EuroQol-A new facility for the measurement of health-related quality of life. Health Policy, 16, 199-208.
20. Feeny, D., Furlong, W., Torrance, G.W., Goldsmith, C.H., Zhu, Z., etal. (2002). Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Medical Care, 40, 113-128.
21. Glasgow, R.E., Doria-Rose, V.P., Khoury, M.J., Elzarrad, M., Brown, M.L., & Stange, K.C. (2013). Comparative effectiveness research in cancer: What has been funded and what knowledge gaps remain? Journal of the National Cancer Institute, 105, 766-773.
22. Glasgow, R.E., & Steiner, J.F. (2012). Comparative effectiveness research to accelerate translation: Recommendations for an emerging field of science. In R.C. Brownson, G.A. Colditz, & E.K. Proctor (Eds.), Dissemination and implementation research in health (pp. 72-92). New York, NY: Oxford University Press.
23. Glasgow, R.E., Vinson, C., Chambers, D., Khoury, M.J., Kaplan, R.M., & Hunter, C. (2012). National Institutes of Health approaches to dissemination and implementation science: Current and future directions. American Journal of Public Health, 102, 1274-1281.
24. Gold, M., Siegel, J., Russell, L., & Weinstein, M. (1996). Cost effectiveness in health and medicine. New York, NY: Oxford University Press.
25. Goldsmith, K., Dyer, M., Buxton, M., & Sharples, L. (2010). Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease. Health and Quality of Life Outcomes, 8, 54.
26. Gotham, K., Pickles, A., & Lord, C. (2009). Standardizing ADOS scores for a measure of severity in autism spectrum disorders. Journal of Autism and Developmental Disorder, 39, 693-705.
27. Greenberg, D., & Neumann, P.J. (2011). Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions? Expert Review of Pharmacoeconomics & Outcomes Research, 11, 113-119.
28. Grosse, S.D., Prosser, L.A., Asakawa, K., & Feeny, D. (2010). QALY weights for neurosensory impairments in pediatric economic evaluations: Case studies and a critique. Expert Review of Pharmacoeconomics & Outcomes Research, 10, 293-308.
29. Horsman, J., Fulong, W., Feeny, D., & Torrance, G. (2003). The Health Utilities Index (HUI®): Concepts, measurement properties and applications. Health and Quality of Life Outcomes, 1, 54.
30. Howlin, P., Goode, S., Hutton, J., & Rutter, M. (2004). Adult outcome for children with autism. Journal of Child Psychology and Psychiatry, 45, 212-229.
31. Howlin, P., Magiati, I., & Charman, T. (2009). Systematic review of early intensive behavioral interventions for children with autism. American Journal on Intellectual and Developmental Disabilities, 114, 23-41.
32. Interagency Autism Coordinating Committee. (2011). 2011 IACC strategic plan for autism spectrum disorder research. Retrieved October 3, 2012, from http://iacc.hhs.gov/strategic-plan/2011/IACC_2011_Strategic_Plan.pdf
33. Khan, K.A., Petrou, S., Rivero-Arias, O., Walters, S.J., & Boyle, S.E. (2014). Mapping EQ-5D utility scores from the PedsQL generic core scales. Pharmacoeconomics, 32, 693-706. doi:10.1007/s40273-014-0153-y; April 9.
34. Kohavi, R. (1995). A study of cross-validation and bootstrap for accuracy estimation and model selection. Proceedings of the 14th International Joint Conference on Artificial Intelligence, 2, 1137-1143.
35. Kuhlthau, K., Orlich, F., Hall, T., Sikora, D., Kovacs, E., etal. (2010). Health-related quality of life in children with autism spectrum disorders: Results from the autism treatment network. Journal of Autism and Developmental Disorders, 40, 721-729.
36. Lipscomb, J., Drummond, M., Fryback, D., Gold, M., & Revicki, D. (2009). Retaining, and enhancing, the QALY. Value in Health, 12(Suppl. 1), S18-S26.
37. Long, S., & Ervin, L. (2000). Using heteroscedasticity consistent standard errors in the linear regression model. The American Statistician, 54, 217-224.
38. Longworth, L., Buxton, M., Sculpher, M., & Smith, D. (2005). Estimating utility data from clinical indicators for patients with stable angina. European Journal of Health Economics, 6, 347-353.
39. Longworth, L.J., & Rowen, D. (2011). NICE DSU technical support document 10: The use of mapping methods to estimate health state utility values. Decision Support Unit, ScHARR, University of Sheffield, Sheffield, UK.
40. Lord, C., & Bishop, S.L. (2010). Autism spectrum disorders: Diagnosis, prevalence, and services for children and families. Society for Research in Child Development. Sharing Child and Youth Development Knowledge. Social Policy Report, 24, 1-25.
41. Lord, C., & McGee, J. (2001). Educating children with autism. Washington, DC: National Academies Press.
42. Lord, C., Risi, S., Lambrecht, L., Cook, E.H. Jr., Leventhal, B.L., etal. (2000). The Autism Diagnostic Observation Schedule-Generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205-223.
43. Luo, N., Johnson, J.A., & Coons, S.J. (2010). Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Medical Care, 48, 365-371.
44. Meltzer, D.O., & Smith, P.C. (2012). Theoretical issues relevant to the economic evaluation of health technologies. In V.P. Mark, T.G. McGuire, & P.P. Barros (Eds.), Handbook of health economics (Vol. 2, pp. 433-469). Amsterdam: Elsevier Science Ltd.
45. Mullen, E. (1997). Mullen Scales of Early Learning. Los Angeles, CA: Western Psychological Services.
46. Myers, S.M., Johnson, C.P., & the Council on Children With Disabilities. (2007). Management of children with autism spectrum disorders. Pediatrics, 120, 1162-1182.
47. The National Autism Center. (2009). National standards report. Randolph, MA: National Autism Center.
48. The National Institute for Health and Care Excellence. (2013). Guide to the methods of technology appraisal 2013. London, England: The National Institute for Health and Care Excellence.
49. National Institute for Health and Clinical Excellence (NICE). (2008). Guide to the methods of technology appraisal. London: NICE.
50. Neumann, P.J., Goldie, S.J., & Weinstein, M.C. (2000). Preference-based measures in economic evaluation in health care. Annual Review of Public Health, 21, 587-611.
51. Neumann, P.J., & Greenberg, D. (2009). Is the United States ready for QALYs? Health Affairs (Project Hope), 28, 1366-1371.
52. Payakachat, N., Summers, K.H., Pleil, A.M., Murawski, M.M., Thomas, J. III, etal. (2009). Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration. Quality of Life Research, 18, 801-813.
53. Payakachat, N., Tilford, J.M., Kovacs, E., & Kuhlthau, K. (2012). Autism spectrum disorders: A review of measures for clinical, health services and cost-effectiveness applications. Expert Review of Pharmacoeconomics & Outcomes Research, 12, 485-503.
54. Petrou, S., Johnson, S., Wolke, D., Hollis, C., Kochhar, P., & Marlow, N. (2010). Economic costs and preference-based health-related quality of life outcomes associated with childhood psychiatric disorders. The British Journal of Psychiatry, 197, 395-404.
55. Petrou, S., & Kupek, E. (2009). Estimating preference-based Health Utilities Index Mark 3 utility scores for childhood conditions in England and Scotland. Medical Decision Making, 29, 291-303.
56. Pregibon, D. (1980). Goodness of link tests for generalized linear models. Applied Statistics, 29, 15-24.
57. Prince, F.H.M., Geerdink, L.M., Borsboom, G.J.J.M., Twilt, M., van Rossum, M.A.J., etal. (2010). Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis. Annals of the Rheumatic Diseases, 69, 138-142.
58. Prosser, L.A., Grosse, S.D., Kemper, A.R., Tarini, B.A., & Perrin, J.M. (2012). Decision analysis, economic evaluation, and newborn screening: Challenges and opportunities. Genetics in Medicine, 14, 703-712.
59. Prosser, L.A., Hammitt, J.K., & Keren, R. (2007). Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: Theoretical and methodological considerations. Pharmacoeconomics, 25, 713-726.
60. Pullenayegum, E.M., Tarride, J.E., Xie, F., Goeree, R., Gerstein, H.C., & O'Reilly, D. (2010). Analysis of health utility data when some subjects attain the upper bound of 1: Are Tobit and CLAD models appropriate? Value in Health, 13, 487-494.
61. Ramsey, J. (1969). Tests for specification error in classical linear least squares regression analysis. Journal of the Royal Statistical Society Series B, 31, 350-371.
62. Roid, G. (2003). Stanford-Binet Intelligence Scales (5th ed.). Itasca, IL: Riverside Publishing.
63. Rothenberg, B., & Samson, D. (2009). Early intensive behavioral intervention based on applied behavior analysis among children with autism spectrum disorders. Technology Evaluation Center Assessment Program. Executive Summary, 23, 1-61.
64. SAS Institute Inc. (2011). The MI procedure. In SAS/STAT 9.3 user's guide, SAS Institute Inc, Cary, NC, p. 4610.
65. Scottish Intercollegiate Guidelines Network. (2007). Assessment, diagnosis and clinical interventions for children and young people with autism spectrum disorders. A national clinical guideline. (Rep. No. SIGN Publication No. 98). Scottish Intercollegiate Guidelines Network (SIN), Edinburgh, Scotland.
66. Seiber, W.J., Groessl, E.J., Ganiats, T.G., & Kaplan, R.M. (2008). Quality of Well Being Self-Administered (QWB-SA) Scale: User's manual. Health Services Research Center, University of California, San Diego, San Diego, CA.
67. Shumway, S., Farmer, C., Thurm, A., Joseph, L., Black, D., & Golden, C. (2012). The ADOS calibrated severity score: Relationship to phenotypic variables and stability over time. Autism Research, 5, 267-276.
68. Sparrow, S.S., Cicchetti, D.V., & Balla, D.A. (2005). Vineland Adaptive Behavior Scales (2nd ed.). Circle Pines, MN: American Guidance Services, Inc.
69. Stevens, K. (2010). Valuation of the Child Health Utility Index 9D (CHU9D). Pharmacoeconomics, 30, 729-747.
70. Tilford, J.M., Payakachat, N., Kovacs, E., Pyne, J.M., Brouwer, W., etal. (2012). Preference-based health-related quality of life outcomes in children with autism spectrum disorders: A comparison of generic instruments. Pharmacoeconomics, 30, 1-19.
71. Ungar, W.J. (2007). Paediatric health economic evaluations: A world view. Healthcare Quarterly, 10, 134-135.
72. Ungar, W.J. (2010). Economic evaluation in child health. New York, NY: Oxford Publisher Press.
73. Ungar, W.J. (2011). Challenges in health state valuation in paediatric economic evaluation: Are QALYs contraindicated? Pharmacoeconomics, 29, 641-652.
74. Varni, J.W., Burwinkle, T.M., Seid, M., & Skarr, D. (2003). The PedsQLTM 4.0 as a pediatric population health measure: Feasibility, reliability, and validity. Ambulatory Pediatrics, 3, 329-341.
75. TM version 4.0 generic core scales in healthy and patient populations. Medical Care, 39, 800-812.
76. Versteegh, M.M., Leunis, A., Luime, J.J., Boggild, M., Uyl-de Groot, C.A., & Stolk, E.A. (2012). Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D. Medical Decision Making, 32, 554-568.
77. Versteegh, M.M., Rowen, D., Brazier, J.E., & Stolk, E.A. (2010). Mapping onto EQ-5D for patients in poor health. Health and Quality of Life Outcomes, 8, 141-148.
78. Wallander, J.L., Dekker, M.C., & Koot, H.M. (2006). Risk factors for psychopathology in children with intellectual disability: A prospective longitudinal population-based study. Journal of Intellectual and Disability Research, 50, 259-268.
79. Warren, Z., McPheeters, M.L., Sathe, N., Foss-Feig, J.H., Glasser, A., & Veenstra-VanderWeele, J. (2011). A systematic review of early intensive intervention for autism spectrum disorders. Pediatrics, 127, e1303-e1311.
80. Weinstein, M.C., Siegel, J.E., Gold, M.R., Kamlet, M.S., & Russell, L.B. (1996). Recommendations of the panel on cost-effectiveness in health and medicine. JAMA: The Journal of the American Medical Association, 276, 1253-1258.
81. Wille, N., Badia, X., Bonsel, G., Burström, K., Cavrini, G., etal. (2010). Development of the EQ-5D-Y: A child-friendly version of the EQ-5D. Quality of Life Research, 19, 875-886.